Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC

por Tegethoff, Jana, Bischoff, Roland, Saleh, Sawsan, Blagojevic, Biljana, Merz, Karl-Heinz, Cheng, Xinlai
Publicado 2017

MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention

por Weigel, Bettina, Tegethoff, Jana F., Grieder, Sarah D., Lim, Bryce, Nagarajan, Bhuvaneswari, Liu, Yu-Chao, Truberg, Jule, Papageorgiou, Dimitris, Adrian-Segarra, Juan M., Schmidt, Laura K., Kaspar, Janina, Poisel, Eric, Heinzelmann, Elisa, Saraswat, Manu, Christ, Marleen, Arnold, Christian, Ibarra, Ignacio L., Campos, Joaquin, Krijgsveld, Jeroen, Monyer, Hannah, Zaugg, Judith B., Acuna, Claudio, Mall, Moritz
Publicado 2023